Format

Send to

Choose Destination
Drug Discov Today Technol. 2013 Sep;10(3):e365-72. doi: 10.1016/j.ddtec.2012.07.004.

Modeling of human tumor xenografts and dose rationale in oncology.

Abstract

Xenograft models are commonly used in oncology drug development. Although there are discussions about their ability to generate meaningful data for the translation from animal to humans, it appears that better data quality and better design of the preclinical experiments, together with appropriate data analysis approaches could make these data more informative for clinical development. An approach based on mathematical modeling is necessary to derive experiment-independent parameters which can be linked with clinically relevant endpoints. Moreover, the inclusion of biomarkers as predictors of efficacy is a key step towards a more general mechanism-based strategy.

PMID:
24050133
DOI:
10.1016/j.ddtec.2012.07.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center